miR-100 Inhibits Cell Growth and Proliferation by Targeting HOXA1 in Nasopharyngeal Carcinoma

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.v68.630207593
   PubMed Web of Science ®Google Scholar
• Sun X, Su S, Chen C, et al. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol. 2014;110:398–403. doi:10.1016/j.radonc.2013.10.02024231245
   PubMed Web of Science ®Google Scholar
• Vishnoi A, Rani S. MiRNA biogenesis and regulation of diseases: an overview. Methods Mol Biol. 2017;1509:1–10.27826912
   PubMedGoogle Scholar
• Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M. microRNAs in cancer management. Lancet Oncol. 2012;13(6):e249–e258. doi:10.1016/S1470-2045(12)70073-622652233
   PubMed Web of Science ®Google Scholar
• Chen B, Xia Z, Deng YN, et al. Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosis. Open Biol. 2019;9(1):180212. doi:10.1098/rsob.18021230958116
   PubMed Web of Science ®Google Scholar
• Adhami M, Haghdoost AA, Sadeghi B, Malekpour Afshar R. Candidate miRNAs in human breast cancer biomarkers: a systematic review. Breast Cancer. 2018;25(2):198–205. doi:10.1007/s12282-017-0814-829101635
   PubMed Web of Science ®Google Scholar
• Ebert MS, Sharp PA. Roles of microRNAs in conferring robustness to biological processes. Cell. 2012;149(3):515–524. doi:10.1016/j.cell.2012.04.00522541426
   PubMed Web of Science ®Google Scholar
• Rupaimoole R, Calin GA, Lopez-Berestein G, Sood AK. miRNA deregulation in cancer cells and the tumor microenvironment. Cancer Discov. 2016;6(3):235–246. doi:10.1158/2159-8290.CD-15-089326865249
   PubMed Web of Science ®Google Scholar
• Lin S, Gregory RI. MicroRNA biogenesis pathways in cancer. Nat Rev Cancer. 2015;15(6):321–333. doi:10.1038/nrc393225998712
   PubMed Web of Science ®Google Scholar
• Chen HC, Chen GH, Chen YH, et al. MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer. 2009;100(6):1002–1011.19293812
   PubMed Web of Science ®Google Scholar
• Li T, Chen JX, Fu XP, et al. microRNA expression profiling of nasopharyngeal carcinoma. Oncol Rep. 2011;25(5):1353–1363. doi:10.3892/or.2011.120421373758
   PubMed Web of Science ®Google Scholar
• Liu N, Chen NY, Cui RX, et al. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol. 2012;13(6):633–641. doi:10.1016/S1470-2045(12)70102-X22560814
   PubMed Web of Science ®Google Scholar
• Zheng Z, Qu JQ, Yi HM, et al. MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-kB signaling pathway. Cell Death Dis. 2017;8(6):e2855. doi:10.1038/cddis.2017.21128569771
   PubMedGoogle Scholar
• Liang TS, Zheng YJ, Wang J, Zhao JY, Yang DK, Liu ZS. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2. J Exp Clin Cancer Res. 2019;38(1):97. doi:10.1186/s13046-019-1023-430791932
   PubMed Web of Science ®Google Scholar
• Li YQ, He Q, Wen X, et al. EZH2-DNMT1-mediated epigenetic silencing of miR-142-3p promotes metastasis through targeting ZEB2 in nasopharyngeal carcinoma. Cell Death Differ. 2019;26(6):1089–1106. doi:10.1038/s41418-018-0208-230353102
   PubMed Web of Science ®Google Scholar
• Bao L, You B, Shi S, et al. Metastasis-associated miR-23a from nasopharyngeal carcinoma-derived exosomes mediates angiogenesis by repressing a novel target gene TSGA10. Oncogene. 2018;37(21):2873–2889. doi:10.1038/s41388-018-0183-629520105
   PubMed Web of Science ®Google Scholar
• Qin C, Huang RY, Wang ZX. Potential role of miR-100 in cancer diagnosis, prognosis, and therapy. Tumour Biol. 2015;36(3):1403–1409. doi:10.1007/s13277-015-3267-825740059
   PubMedGoogle Scholar
• Li C, Gao Y, Zhang K, et al. Multiple roles of miroRNA-100 in human cancer and its therapeutic potential. Cell Physiol Biochem. 2015;37(6):2143–2159. doi:10.1159/00043857226606597
   PubMedGoogle Scholar
• Sun X, Liu X, Wang Y, Yang S, Chen Y, Yuan T. miR-100 inhibits the migration and invasion of nasopharyngeal carcinoma by targeting IGF1R. Oncol Lett. 2018;15(6):8333–8338. doi:10.3892/ol.2018.842029805566
   PubMed Web of Science ®Google Scholar
• Zhou SM, Zhang F, Chen XB, et al. miR-100 suppresses the proliferation and tumor growth of esophageal squamous cancer cells via targeting CXCR7. Oncol Rep. 2016;35(6):3453–3459. doi:10.3892/or.2016.470127035873
   PubMed Web of Science ®Google Scholar
• Liu J, Lu KH, Liu ZL, Sun M, De W, Wang ZX. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1. BMC Cancer. 2012;12:519. doi:10.1186/1471-2407-12-51923151088
   PubMed Web of Science ®Google Scholar
• Gebeshuber CA, Martinez J. miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling. Oncogene. 2013;32(27):3306–3310. doi:10.1038/onc.2012.37222926517
   PubMed Web of Science ®Google Scholar
• Xiao F, Bai Y, Chen Z, et al. Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100. Eur J Cancer. 2014;50:1541–1554. doi:10.1016/j.ejca.2014.01.02424559685
   PubMed Web of Science ®Google Scholar
• Wang G, Chen L, Meng J, Chen M, Zhuang L, Zhang L. Overexpression of microRNA-100 predicts an unfavorable prognosis in renal cell carcinoma. Int Urol Nephrol. 2013;45:373–379. doi:10.1007/s11255-012-0374-y23378187
   PubMed Web of Science ®Google Scholar
• Huang JS, Egger ME, Grizzle WE, McNally LR. MicroRNA-100 regulates IGF1-receptor expression in metastatic pancreatic cancer cells. Biotech Histochem. 2013;88:397–402. doi:10.3109/10520295.2012.76246023373509
   PubMed Web of Science ®Google Scholar
• Shi DB, Wang YW, Xing AY, et al. C/EBPα-induced miR-100 expression suppresses tumor metastasis and growth by targeting ZBTB7A in gastric cancer. Cancer Lett. 2015;369(2):376–385. doi:10.1016/j.canlet.2015.08.02926404754
   PubMed Web of Science ®Google Scholar
• Zheng YS, Zhang H, Zhang XJ, et al. MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia. Oncogene. 2012;31(1):80–92. doi:10.1038/onc.2011.20821643017
   PubMed Web of Science ®Google Scholar
• Zhou HC, Fang JH, Luo X, et al. Downregulation of microRNA-100 enhances the ICMT-Rac1 signaling and promotes metastasis of hepatocellular carcinoma cells. Oncotarget. 2014;5(23):12177–12188. doi:10.18632/oncotarget.260125361001
   PubMedGoogle Scholar
• Xu C, Zeng Q, Xu W, et al. MiRNA-100inhibits human bladder urothelial carcinogenesis by directly targeting mTOR. Mol Cancer Ther. 2013;12:207–219. doi:10.1158/1535-7163.MCT-12-027323270926
   PubMed Web of Science ®Google Scholar
• Tovar V, Alsinet C, Villanueva A, et al. IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage. J Hepatol. 2010;52:550–559. doi:10.1016/j.jhep.2010.01.01520206398
   PubMed Web of Science ®Google Scholar
• Li BH, Zhou JS, Ye F, et al. ReducedmiR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein. Eur J Cancer. 2011;47:2166–2174. doi:10.1016/j.ejca.2011.04.03721636267
   PubMed Web of Science ®Google Scholar
• Jin Y, Tymen SD, Chen D, et al. MicroRNA-99 family targets AKT-mTOR signaling pathway in dermal wound healing. PLoS ONE. 2013;8(5):e64434. doi:10.1371/journal.pone.006443423724047
   PubMed Web of Science ®Google Scholar
• Peng H, Luo J, Hao H, et al. MicroRNA-100 regulates SW620 colorectal cancer cell proliferation and invasion by targeting RAP1B. Oncol Rep. 2014;31(5):2055–2062. doi:10.3892/or.2014.307524626817
   PubMed Web of Science ®Google Scholar
• Luan Y, Zhang S, Zuo L, Zhou L. Overexpression of miR-100 inhibits cell proliferation, migration, and chemosensitivity in human glioblastoma through FGFR3. Onco Targets Ther. 2015;8:3340–3391. doi:10.2147/OTT.S85677
   Web of Science ®Google Scholar
• Chen D, Sun Y, Yuan Y, et al. miR-100 induces epithelial-mesenchymal transition but suppresses tumorigenesis, migration and invasion. PLoS Genet. 2014;10:e1004177. doi:10.1371/journal.pgen.100417724586203
   PubMed Web of Science ®Google Scholar
• Li Q, Zhang X, Li N, Liu Q, Chen D. miR-30b inhibits cancer cell growth, migration, and invasion by targeting homeobox A1 in esophageal cancer. Biochem Biophys Res Commun. 2017;485(2):506–512. doi:10.1016/j.bbrc.2017.02.01628189678
   PubMed Web of Science ®Google Scholar
• Wang JG, Tang WP, Liao MC, Liu YP, Ai XH. MiR-99a suppresses cell invasion and metastasis in nasopharyngeal carcinoma through targeting HOXA1. Onco Targets Ther. 2017;10:753–761. doi:10.2147/OTT.S12678128228659
   PubMed Web of Science ®Google Scholar
• Han S, Liu Z, Wang Y, et al. MicroRNA-577 inhibits the migration and invasion of hepatocellular carcinoma cells by targeting homeobox A1. Oncol Rep. 2018;39(6):2987–2995. doi:10.3892/or.2018.638829693150
   PubMed Web of Science ®Google Scholar
• Wang H, Liu G, Shen D, et al. HOXA1 enhances the cell proliferation, invasion and metastasis of prostate cancer cells. Oncol Rep. 2015;34(3):1203–1210. doi:10.3892/or.2015.408526135141
   PubMed Web of Science ®Google Scholar
• Yuan C, Zhu X, Han Y, et al. Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1. J Exp Clin Cancer Res. 2016;35:15. doi:10.1186/s13046-016-0294-226791264
   PubMed Web of Science ®Google Scholar
• Taminiau A, Draime A, Tys J, et al. HOXA1 binds RBCK1/HOIL-1 and TRAF1 and modulates the TNF/NF-kB pathway in a transcription-independent manner. Nucleic Acids Res. 2016;44(15):4349–7331. doi:10.1093/nar/gkw606
   Web of Science ®Google Scholar